Dam, S.L.; Masselink-Haverkate, H.M.; Gant, C.M.; Bakker, S.J.L.; Nijboer, R.M.; Kruik-Kollöffel, W.J.; Laverman, G.D.
Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT): The Role of Patient Adherence and Physician’s Follow-Up Action. Pharmacoepidemiology 2023, 2, 307-319.
https://doi.org/10.3390/pharma2040026
AMA Style
Dam SL, Masselink-Haverkate HM, Gant CM, Bakker SJL, Nijboer RM, Kruik-Kollöffel WJ, Laverman GD.
Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT): The Role of Patient Adherence and Physician’s Follow-Up Action. Pharmacoepidemiology. 2023; 2(4):307-319.
https://doi.org/10.3390/pharma2040026
Chicago/Turabian Style
Dam, Simone L., Heleen M. Masselink-Haverkate, Christina M. Gant, Stephan J. L. Bakker, Roos M. Nijboer, Willemien J. Kruik-Kollöffel, and Gozewijn D. Laverman.
2023. "Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT): The Role of Patient Adherence and Physician’s Follow-Up Action" Pharmacoepidemiology 2, no. 4: 307-319.
https://doi.org/10.3390/pharma2040026
APA Style
Dam, S. L., Masselink-Haverkate, H. M., Gant, C. M., Bakker, S. J. L., Nijboer, R. M., Kruik-Kollöffel, W. J., & Laverman, G. D.
(2023). Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT): The Role of Patient Adherence and Physician’s Follow-Up Action. Pharmacoepidemiology, 2(4), 307-319.
https://doi.org/10.3390/pharma2040026
